An anti-apoptotic baculovirus expression vector
By introducing small RNA expression cassettes targeting Sf-caspase-1 and Tn-caspase-1 into baculovirus vectors, the problem of low recombinant protein yield caused by insect cell apoptosis was solved, enabling efficient expression of exogenous genes in Sf and Tn cell lines and advancing the industrial application of anti-apoptotic vectors.
Patent Information
- Application Number
- CN202211099000.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2018-06-21
- Publication Date
- 2026-04-14
- Estimated Expiration
- 2038-06-21
AI Technical Summary
In existing baculovirus expression systems, insect cells undergo apoptosis shortly after infection, resulting in limited recombinant protein production. In particular, the lack of simultaneously effective anti-apoptotic vectors in Sf and Tn cell lines limits their industrial application.
We designed and cloned a small RNA expression cassette targeting the shared sequences of Sf-caspase-1 and Tn-caspase-1 into the genome of a baculovirus vector. The cassette contained the human U6 promoter, a 21nt guide strand complement sequence, a 9nt loop sequence, and a transcription termination signal, which reduced the tendency of the DNA strand to form hairpin structures and constructed an anti-apoptotic recombinant baculovirus vector.
It significantly improved the expression level of exogenous genes and protein production in Sf9 and High Five cells, increased luciferase activity by about 1 time, and prolonged the survival time of infected cells, making it suitable for the industrial production of protein drugs and vaccines.